AI Insights
Artificial Intelligence in Healthcare Market to Reach USD
Mordor Intelligence has published a new report on the Artificial Intelligence in Healthcare Market offering a comprehensive analysis of trends, growth drivers, and future projections.
Introduction
According to a 2025 report on AI in healthcare market by Mordor Intelligence, the market is estimated at USD 39.92 billion in 2025 and is projected to reach USD 196.91 billion by 2030, growing at a CAGR of 37.60 percent during the forecast period.
The artificial intelligence in the healthcare market [https://www.mordorintelligence.com/industry-reports/artificial-intelligence-in-healthcare-market?utm_source=abnewswire] is witnessing rapid growth as hospitals, pharmaceutical companies, and healthcare providers increasingly adopt AI tools to improve patient care and operational efficiency. AI is used for a range of applications including diagnostics, imaging analysis, drug discovery, virtual assistants, and patient management.
Key Market Trends
AI in Diagnostics and Imaging
AI tools are widely used to analyze medical images such as X-rays, MRIs, and CT scans. Hospitals and diagnostic centers are adopting AI-powered imaging solutions to detect diseases like cancer, neurological conditions, and cardiovascular diseases with higher accuracy and speed. This reduces diagnostic errors and supports clinicians in providing timely treatment.
Use of AI in Drug Discovery and Development
Pharmaceutical companies are leveraging AI platforms to identify new drug candidates, analyze molecular structures, and predict drug responses. AI is helping reduce the time and cost involved in drug development by accelerating research, screening compounds efficiently, and supporting clinical trial processes.
Growth of Virtual Health Assistants and Chatbots
AI-based virtual assistants are being used in hospitals and clinics for appointment scheduling, medication reminders, answering patient queries, and post-discharge follow-ups. This trend is helping healthcare providers reduce administrative workloads and improve patient engagement and satisfaction.
Application of AI in Personalized Medicine
AI enables analysis of patient-specific data including genetic information, medical history, and lifestyle factors to recommend tailored treatment plans. This is supporting the growth of personalized medicine, especially in oncology, where targeted therapies are crucial for effective treatment outcomes.
Adoption of AI for Administrative Workflow Automation
Hospitals and healthcare providers are using AI to automate administrative tasks such as billing, claim processing, and patient data management. This trend is helping reduce operational costs, minimize errors in records, and improve workflow efficiency across departments.
Market Segmentation
By Technology
Machine Learning, Deep Learning, NLP, Computer Vision, Generative AI/Foundation Models, Reinforcement Learning, Others
These technologies form the backbone of AI healthcare tools. Machine learning and deep learning power predictive analytics and image interpretation, while NLP supports automated documentation and clinical decision support. Emerging technologies like generative AI and foundation models which are expanding at roughly 48% CAGR represent the fastest-growing tech area.
By Application
Robotassisted Surgery, Virtual Assistants, Precision & Personalized Medicine, Remote patient Monitoring, Fraud Detection, Others
AI is applied across care delivery and support systems. It’s used in robotic surgery, intelligent scheduling assistants, and automated billing workflows. Diagnostic imaging remains a dominant use case, with AI helping analyze scans and track disease progression. AI also supports clinical trials with data management, and aids in fraud detection and cybersecurity in patient records
By Offering
Hardware, Software, Services
Offerings in AI healthcare span physical devices, digital tools, and consultancy/support services. Software, which includes AI platforms and specialized applications, holds a significant market share given hospitals’ reliance on digital diagnostics, workflow optimization, and predictive analytics.
By End User
Hospitals & Healthcare Providers, Patients, Pharmaceutical & Biotechnology Companies, Healthcare Payers, Others
This segmentation captures the diverse customer base for AI solutions. Hospitals and providers make up the bulk of users for diagnostic or workflow tools. Patients benefit indirectly via virtual health apps or monitoring. Pharma and biotech firms use AI for drug discovery and trial enhancement. Payers leverage AI in claims processing, fraud detection, and cost management.
By Geography
North America, Europe, AsiaPacific, Middle East & Africa, South America
Geographic segmentation highlights regional differences: North America leads due to its healthcare infrastructure and investment capacity, while AsiaPacific is identified as the fastest-growing due to rising digital adoption and government-backed health tech initiatives
Key Players
*
IBM Corporation A leading AI healthcare provider, IBM offers robust diagnostic and analytics solutions such as the Watson Health platform that assist hospitals and clinics in decision support, oncology, and imaging workflows.
*
Google LLC (Alphabet) Through its Google Health and DeepMind divisions, Google is developing AI-enabled medical imaging tools and predictive health models. Its efforts include diabetic retinopathy detection and cardiology risk prediction, leveraging advanced AI algorithms.
*
NVIDIA Corporation NVIDIA delivers critical AI infrastructure including GPUs and deeplearning frameworks that support healthcare AI applications in diagnostics and image processing. Healthcare institutions rely on hardware acceleration for largescale AI deployment.
*
Microsoft Corporation Microsoft provides AI services integrated into Azure and its healthcare cloud, supporting predictive insights, imaging analysis, and seamless EHR integration for clinician support
Conclusion
The AI in the healthcare market is experiencing strong growth, supported by the increasing demand for diagnostic accuracy, efficient hospital workflows, and personalized care solutions. The use of AI in diagnostics, imaging, drug discovery, and patient management is expected to rise further as hospitals and pharmaceutical companies seek cost-effective, data-driven decision-making tools.
North America will continue to lead in terms of market share, while Asia-Pacific will emerge as a key growth region due to its expanding healthcare infrastructure and government initiatives in digital health. Key players are focusing on enhancing their AI capabilities through continuous investment in research, partnerships with healthcare providers, and expanding AI applications in various medical fields.
Get more insights: https://www.mordorintelligence.com/industry-reports/artificial-intelligence-in-healthcare-market?utm_source=abnewswire
Industry Related Reports
Artificial Intelligence in Medicine Market: [https://www.mordorintelligence.com/industry-reports/artificial-intelligence-in-medicine-market?utm_source=abnewswire] The Artificial Intelligence (AI) in Healthcare Market report is segmented by Application Type (Medical Administration and Support, Patient Management, Research and Development, Other Applications), by Type (Hardware, Software, Services), and by Geography (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa). The report offers market forecasts and size in value (USD) for all the above segments.
North America Artificial Intelligence in Healthcare Market: The Artificial Intelligence in Healthcare Market North America report segments the industry into by Technology (Natural Language Processing (NLP), and more), by Application (Robot-assisted Surgery, and more), by Offering (Hardware, Software, Services), by End User (Healthcare Payers, and more), and by Geography (United States, and more).
For More information: https://www.mordorintelligence.com/industry-reports/north-america-artificial-intelligence-in-healthcare-market?utm_source=abnewswire
AI In Medical Billing Market: [https://www.mordorintelligence.com/industry-reports/ai-in-medical-billing-market?utm_source=abnewswire] The AI in Medical Billing Market report segments the industry into by Deployment (Cloud, On-Premises), by Applications (Automated Billing and Documentation, Claims Processing, Fraud Detection, Other Applications), by End Users (Hospitals and Clinics, Healthcare Payers, Ambulatory Surgical Centers, Other End Users), and by Geography (North America, Europe, Asia, Australia and New Zealand, Latin America, Middle East and Africa).
About Mordor Intelligence: Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
For any inquiries or to access the full report, please contact:media@mordorintelligence.com https://www.mordorintelligence.com/
Media Contact
Company Name: Mordor Intelligence Private Limited
Contact Person: Jignesh Thakkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=artificial-intelligence-in-healthcare-market-to-reach-usd-19691-billion-by-2030-driven-by-diagnostics-and-imaging-applications]
Phone: +1 617-765-2493
Address:5th Floor, Rajapushpa Summit, Nanakramguda Rd, Financial District, Gachibowli
City: Hyderabad
State: Telangana 500008
Country: India
Website: https://www.mordorintelligence.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
AI Insights
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
Tokyo-based Chugai Pharmaceutical is joining with the AI-driven biotech Gero, in a research collaboration on age-related diseases potentially worth more than $1 billion.
The collaboration will see Chugai, majority owned by Roche, creating novel antibody drug candidates using its in-house engineering capabilities. The targets sought by those antibodies will be discovered using Gero’s AI target discovery platform, which serves as predictive models of human health trained on longitudinal medical records. Chugai will get exclusive worldwide rights to any drug candidates made in the collaboration.
Under terms of the deal, Chugai will make an undisclosed upfront payment and put up approximately $250 million if certain unannounced development or sales milestones are reached. If Chugai successfully launches a product, the company will pay Gero additional royalties, which could push the total value of the deal to above $1 billion, according to an email sent to BioSpace from a Chugai representative.
Though the companies did not announce any specific indications they will be targeting in the collaboration, Singapore-based Gero’s stated cause is to eliminate the “root causes of age-related diseases.”
“Our AI platform is built to identify therapeutic targets that drive multiple age-related diseases and potentially aging itself,” Gero CEO Peter Fedichev said in a statement. “In this collaboration, we aim to translate those insights into therapeutics that can help restore the lost function. This partnership with Chugai is an important step toward achieving Gero’s mission: to meaningfully target the biological processes of human aging.”
Gero previously inked a deal with Pfizer in January 2023 to apply its AI technology platform to discover targets in fibrotic diseases. Financial terms of that deal were not disclosed, only that Gero would receive an upfront payment and be eligible to receive discovery milestone payments. Gero appears to still be in its early stages, having raised a $6 million series A round in 2023. The company does not have a published drug pipeline on its website.
Chugai, for its part, has partnered with AI companies since late last decade, making it an early entrant into the biopharma-AI space. In 2018 Chugai linked up with the deep learning company Preferred Networks, paying the latter about $5 million (¥700 million) for access to its platform. More recently, Chugai partnered with SoftBank in January to use generative AI to accelerate drug development, with the aim of streamlining personnel and costs associated with clinical trials.
AI Insights
Ascendion Wins Gold as the Artificial Intelligence Service Provider of the Year in 2025 Globee® Awards
- Awarded Gold for excellence in real-world AI implementation and measurable enterprise outcomes
- Recognized for agentic AI innovation through ASCENDION AAVA platform, accelerating software delivery and unlocking business value at scale
- Validated as a category leader in operationalizing AI across enterprise ecosystems—from generative and ethical AI to machine learning and NLP—delivering productivity, transparency, and transformation
BASKING RIDGE, N.J., July 7, 2025 /PRNewswire/ — Ascendion, a leader in AI-powered software engineering, has been awarded Gold as the Artificial Intelligence Service Provider of the Year in the 2025 Globee® Awards for Artificial Intelligence. This prestigious honor recognizes Ascendion’s bold leadership in delivering practical, enterprise-grade AI solutions that drive measurable business outcomes across industries.
The Globee® Awards for Artificial Intelligence celebrate breakthrough achievements across the full spectrum of AI technologies including machine learning, natural language processing, generative AI, and ethical AI. Winners are recognized for setting new standards in transforming industries, enhancing user experiences, and solving real-world problems with artificial intelligence (AI).
“This recognition validates more than our AI capabilities. It confirms the bold vision that drives Ascendion,” said Karthik Krishnamurthy, Chief Executive Officer, Ascendion. “We’ve been engineering the future with AI long before it became a buzzword. Today, our clients aren’t chasing trends; they’re building what’s next with us. This award proves that when you combine powerful AI platforms, cutting-edge technology, and the relentless pursuit of meaningful outcomes, transformation moves from promise to fact. That’s Engineering to the Power of AI in action.”
Ascendion earned this recognition by driving real-world impact with its ASCENDION AAVA platform and agentic AI capabilities, transforming enterprise software development and delivery. This strategic approach enables clients to modernize engineering workflows, reduce technical debt, increase transparency, and rapidly turn AI innovation into scalable, market-ready solutions. Across industries like banking and financial services, healthcare and life sciences, retail and consumer goods, high-tech, and more, Ascendion is committed to helping clients move beyond experimentation to build AI-first systems that deliver real results.
“The 2025 winners reflect the innovation and forward-thinking mindset needed to lead in AI today,” said San Madan, President of the Globee® Awards. “With organizations across the globe engaging in data-driven evaluations, this recognition truly reflects broad industry endorsement and validation.”
About Ascendion
Ascendion is a leading provider of AI-powered software engineering solutions that help businesses innovate faster, smarter, and with greater impact. We partner with over 400 Global 2000 clients across North America, APAC, and Europe to tackle complex challenges in applied AI, cloud, data, experience design, and workforce transformation. Powered by +11,000 experts, a bold culture, and our proprietary Engineering to the Power of AI (EngineeringAI) approach, we deliver outcomes that build trust, unlock value, and accelerate growth. Headquartered in New Jersey, with 40+ global offices, Ascendion combines scale, agility, and ingenuity to engineer what’s next. Learn more at https://ascendion.com.
Engineering to the Power of AI™, AAVA™, EngineeringAI, Engineering to Elevate Life™, DataAI, ExperienceAI, Platform EngineeringAI, Product EngineeringAI, and Quality EngineeringAI are trademarks or service marks of Ascendion®. AAVA™ is pending registration. Unauthorized use is strictly prohibited.
About the Globee® Awards
The Globee® Awards present recognition in ten programs and competitions, including the Globee® Awards for Achievement, Globee® Awards for Artificial Intelligence, Globee® Awards for Business, Globee® Awards for Excellence, Globee® Awards for Cybersecurity, Globee® Awards for Disruptors, Globee® Awards for Impact. Globee® Awards for Innovation (also known as Golden Bridge Awards®), Globee® Awards for Leadership, and the Globee® Awards for Technology. To learn more about the Globee Awards, please visit the website: https://globeeawards.com.
SOURCE Ascendion
AI Insights
Overcoming the Traps that Prevent Growth in Uncertain Times
July 7, 2025
Today, with uncertainty a seemingly permanent condition, executives need to weave adaptability, resilience, and clarity into their operating plans. The best executives will implement strategies that don’t just sustain their businesses; they enable growth.
-
Funding & Business7 days ago
Kayak and Expedia race to build AI travel agents that turn social posts into itineraries
-
Jobs & Careers6 days ago
Mumbai-based Perplexity Alternative Has 60k+ Users Without Funding
-
Mergers & Acquisitions6 days ago
Donald Trump suggests US government review subsidies to Elon Musk’s companies
-
Funding & Business6 days ago
Rethinking Venture Capital’s Talent Pipeline
-
Jobs & Careers6 days ago
Why Agentic AI Isn’t Pure Hype (And What Skeptics Aren’t Seeing Yet)
-
Funding & Business4 days ago
Sakana AI’s TreeQuest: Deploy multi-model teams that outperform individual LLMs by 30%
-
Funding & Business7 days ago
From chatbots to collaborators: How AI agents are reshaping enterprise work
-
Jobs & Careers6 days ago
Astrophel Aerospace Raises ₹6.84 Crore to Build Reusable Launch Vehicle
-
Jobs & Careers6 days ago
Telangana Launches TGDeX—India’s First State‑Led AI Public Infrastructure
-
Jobs & Careers4 days ago
Ilya Sutskever Takes Over as CEO of Safe Superintelligence After Daniel Gross’s Exit